Caisse de Depot et Placement du Quebec (CDPQ)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-557	Closed	-$232K	–	575
2022 Q3	$232K	Sell	557 -33,516	-98%	-$16.7M	﹤0.01%	541
2022 Q2	$16.9M	Sell	34,073 -317	-0.9%	-$165K	0.05%	233
2022 Q1	$19.4M	Sell	34,390 -11,100	-24%	-$6.69M	0.05%	247
2021 Q4	$34.4M	Sell	45,490 -28,400	-38%	-$21.3M	0.07%	198
2021 Q3	$55.1M	Buy	73,890 +35,120	+91%	+$26.3M	0.12%	140
2021 Q2	$25M	Buy	38,770 +761	+2%	+$463K	0.05%	171
2021 Q1	$21.7M	Buy	38,009 +35,464	+1,393%	+$21M	0.05%	160
2020 Q4	$1.48M	Sell	2,545 -455	-15%	-$259K	﹤0.01%	482
2020 Q3	$1.55M	Sell	3,000 -100	-3%	-$50.6K	﹤0.01%	449
2020 Q2	$1.4M	Buy	3,100 +2,200	+244%	+$971K	﹤0.01%	470
2020 Q1	$316K	Buy	+900	New	+$331K	﹤0.01%	686
2019 Q1	–	Sell	-7,000	Closed	-$1.63M	–	743
2018 Q4	$1.63M	Sell	7,000 -10,000	-59%	-$2.68M	﹤0.01%	513
2018 Q3	$5.32M	Buy	+17,000	New	+$5.28M	0.01%	339

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s BIO Position: Q4 2022 in Review

Caisse de Depot et Placement du Quebec (CDPQ) sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2022, closing a stake of 557 shares — an estimated $232K sold.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in BIO in Q3 2018 and held it in 13 quarters. The position peaked at $55.1M in Q3 2021. 471 funds tracked by Wall St. Rank hold BIO as of Q4 2022.

Caisse de Depot et Placement du Quebec (CDPQ) reported no remaining Bio-Rad Laboratories Class A position as of Q4 2022 after selling out during the quarter.
Caisse de Depot et Placement du Quebec (CDPQ) sold 557 Bio-Rad Laboratories Class A shares in Q4 2022, an estimated $232K.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Bio-Rad Laboratories Class A in Q3 2018 and held it in 13 quarters.
Caisse de Depot et Placement du Quebec (CDPQ)'s Bio-Rad Laboratories Class A position peaked at $55.1M in Q3 2021.
471 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2022.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q4 2022, filed 14 Feb 2023.